In glioma, IFI30 was highly expressed in glioblastomas and gliomas with mesenchymal subtypes or wild-type isocitrate dehydrogenase, which indicated that gliomas were highly malignant and had poor prognosis 22. Here, IFI30 is linked to central nervous system cancer.